Shares of Vertex Pharmaceuticals Inc. VRTX slipped 2.92% to $485.89 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 2.24% to ...

BOSTON, April 11, 2025--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Paul Negulescu, Ph.D. Senior Vice President, Vertex has been awarded the 2025 Canada Gairdner ...

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...

In a series of recent legal challenges initiated by the pharmaceutical industry against the US Department of Health and Human Services Office of ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

View the call options (the right to buy) and put options (the right to sell), along with their last price, change, volume and implied volatility for Vertex Pharmaceuticals Inc. Evaluate the prices and ...

We feel now is a pretty good time to analyse Avadel Pharmaceuticals plc's (NASDAQ:AVDL) business as it appears the company may be on the cusp of a considerable accomplishment. Avadel ...

Yee covers the Healthcare sector, focusing on stocks such as Gilead Sciences, Amgen, and Vertex Pharmaceuticals. According to TipRanks, Yee has an average return of -4.0% and a 39.43% success rate ...